Sidoti & Co Downgrades Allion Healthcare (ALLI) to Neutral
ALLI Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Sidoti & Co downgrades Allion Healthcare (Nasdaq: ALLI) to Neutral from Buy. Price target $9.
To see more analyst ratings on ALLI Click Here.
Allion Healthcare, Inc., together with its subsidiaries, provides specialty pharmacy and disease management services focused on human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS) patients in the United States.
To see more analyst ratings on ALLI Click Here.
Allion Healthcare, Inc., together with its subsidiaries, provides specialty pharmacy and disease management services focused on human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS) patients in the United States.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Barclays Cuts Estimates and Price Target on ADP (ADP); Mixed Data From Investor Day
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
Create E-mail Alert Related Categories
DowngradesRelated Entities
Sidoti & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
